Adamas Pharmaceuticals IPO Info
Company Name: Adamas Pharmaceuticals
Stock Symbol: ADMS
Exchange: NASDAQ
Status: Priced
IPO Date: 4/10/2014
IPO Price:
16.00 (
8.56%)
Underwriters
Amount of Offering: N/A
Number of Shares Offered: 3 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system. Adamas achieves this by enhancing the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products. Adamas is currently developing its lead wholly owned product candidate, ADS-5102, for a complication of Parkinson's disease known as levodopa induced dyskinesia and as a treatment for chronic behavioral symptoms associated with traumatic brain injury.
News Headlines
